Antiglokomatöz sabit kombinasyonların etkileri ve hasta uyumunun karşılaştırılması: Dorzolamid-timolol maleat ve latanoprost-timolol maleat

Amaç: Primer açık açılı glokomu olan hastalarda, dorzolamid- timolol maleat (DTSK) ve latanoprost-timolol maleat (LTSK) sabit kombinasyonlarının etkilerini karşılaştırmayı ve tedaviye hasta uyumunu değerlendirmeyi amaçladık. Gereç ve yöntem: LTSK kullanan 24 hastanın 44 gözü, DTSK kullanan 24 hastanın 35 gözü olmak üzere toplam 48 hastanın 79 gözü çalışma kapsamına alındı. Hastalar 6 ay takip edildi. Üçüncü ayda gün içi göz içi basıncı (GİB) dalgalanmalarına bakıldı. Görme alanı ve retina sinir lifi tabakası (RSLT) analizi 6.ayda tekrarlandı. Bulgular: Her iki ilacın da GİBnı ve gün içi dalgalanmalarını etkin bir şekilde kontrol ettiği ve aralarında istatistiksel olarak anlamlı bir fark bulunmadığı gözlendi(p>0.05). Görme alanı ve RSLT ölçümlerinde iki grup arasında istatistiksel olarak anlamlı bir fark yoktu(p>0.05). Başlangıç ve altıncı ay karşılaştırıldığında, MD ve sLV değerlerinde azalma, RSLT ölçümlerinde ise azalma ve artma yönünde değişiklikler istatistiksel olarak anlamlı bulundu(p0.05). Her iki grupta da başlangıçta hastaların çoğu ilaç alımını unutmadı(DTSK %54.2 ve LTSK %66.7). Takip eden kontrollerde, iki grupta da kompliyans ve adherens arttı. İlaç kullanım süresinin kompliyansı etkileyebildiği bulundu (p=0.007). Sonuç: Her iki ilacın da, GİBnı ve gün içi dalgalanmalarını etkin ve klinik olarak yeterli bir şekilde kontrol edebildiği, tolere edilebilir yan etkilere sahip oldukları ve hastaların tedavi uyumlarının yüksek olduğu görüldü.

Comparison of the effects of antiglaucomatous fixed combinations and patients compliance: Dorzolamide-timolol maleate and latanoprost-timolol maleate

Objectives: We aimed to compare the effects of fixed combinations of dorzolamide/timolol maleate (DTFC) and latanoprost/timolol maleate (LTFC) at primary open angle glaucoma patients and assess the patient compliance to treatment. Materials and Methods: Forty-four eyes of 24 patients taking LTFC, 35 eyes of 24 patients taking DTFC and totally 79 eyes of 48 patients were included in this study. Patients were followed for 6 months. At 3rd month, diurnal intraocular pressure (IOP) fluctuations were assessed. Perimetry and retinal nerve fiber layer (RNFL) analyze were repeated at 6th month. Results: Both medicines had efficiently controlled the IOP and diurnal fluctuations and statistically no significant difference was observed (p>0.05). Perimetric and RNFL measurements were not different in both groups(p>0.05). When we have compared the results of baseline and 6th months, MD and sLV values decreased, RNFL in some cases increased on the other hand we have also observed a decrease in some cases(p<0.05). Ocular irritation was the most common side effect in both groups and there was no statistically significant difference between the groups by means of side effects.When compliance and adherence were assessed, there was no statistically significant difference between the groups (p>0.05). Most of the patients did not forget to take their medicines (DTSK %54.2 and LTSK %66.7) and in following visits, compliance and adherence were improved in both groups. It is detected that duration of medicine use may affect the compliance (p=0.007). Conclusion: It is observed that two medicines controlled the IOP and diurnal fluctuations clinically efficient and effectively, had reasonable side effects and had high patient compliance to treatment.

PDF

___

1. Zimmerman R, Sakıyalak D, Krupin T, Rosenberg LF. Primary open-angle glaucoma. Yanoff M, Duker JS. Ophtalmology, Second edition. St. Louis: Mosby, 2004:1482-7.
2. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors of glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003; 121(1): 48-56.
3. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120(6):701-13.
4. Collobaborative Normal-Tension Glaucoma Study Group: The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998;126(4):498-505.
5. Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 1995;26(3):233-6.
6. Miyake K, Ota I, Icbaraki N, et al. Enhanced disruption of the blood-aqueus barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol 2001;119(3):387-94.
7. European Glaucoma Society. Terminology and guidelines for glaucoma, 3nd Edition. Savona: 2008:119.
8.Orhan M. Hümör aköz dinamiği. Turaçlı ME, Önol M, Yalvaç SI. Glokom. Ankara: SFN, 2003;4-10.
9. Turaçlı ME. Tıbbi tedavi. Turaçlı ME, Önol M, Yalvaç SI. Glokom. Ankara: SFN, 2003;162-96.
10. Kurtulmuşoğlu MÖ, Önol M. Glokom Tedavisinde Fiks Kombinasyonlar. Glokom-Katarakt 2007;2(3):149-56.
11. Bayer A. Kombine tıbbi tedavi. Glokom. Türk Oftalmoloji Derneği eğitim yayınları no 9: Epsilon, 2009;379-87.
12. Shin DH, Feldman RM, Sheu WP. Fixed Combination Latanoprost/Timolol Study Group: Efficacy and safety of the fixed combinations latanoprost/yimolol versus dorzolamide/ timolol in patients with elevated intraocular pressure. Ophthalmology 2004;111(2):276-82.
13. Konstas AGP, Kozobolis VP, Lallos N, Christodoulakis E, Stewart JA, Stewart WC. Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005 % / timolol maleate 0.5 % and dorzolamide 2 % / timolol maleate 0.5 %. Eye 2004;18:1264-9.
14. Siesky B, Harris A, Sines D, et al. A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary openangle glaucoma. J Ocul Pharmacol Ther 2006;22(5):353- 61.
15. Cvenkel B, Stewart JA, Nelson LA, Stewart WC. Dorzolamide/ timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension. Current Eye Research 2008;33(2):163-8.
16. Feldman RM. A comparison of fixed combination of latanoprost and timolol with fixed combination of dorzolamide and timolol in patients with elevated intraocular pressure. Invest Ophthalmol Vis Sci 2002;43:E-Abstract 295.
17. VanVeldhuisen PC, Ederer F, Gaasterland DE, , et al. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. American J Ophthalmol 2000;130:429- 40.
18. Williams ZY, Schuman JS, Gamell L, et al. Optical coherence tomography measurement of nerve fiber layer thickness and the likelihood of a visual field defect. Am J Ophthalmol 2002;134(4):538-46.
19. Üstündağ C. Glokomlu gözlerde optik koherens tomografi ile saptanan retina sinir lifi kalınlıklarının görme alanı indeksleri ile korelasyonu. T Oft Gaz 2001;31:600-4.
20. Nordstrom BL , Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 2005;140:598-606.
21. Eren MH, Altan Ç, Akagündüz U, Bayraktar Ş, Yılmaz ÖF. Glokomun medikal tedavisinde hasta uyumu. Glokom-Katarakt 2008;3(3):158-64.